Hamburg Joins Sharfstein On FDA Commissioner Shortlist
This article was originally published in The Rose Sheet
Executive Summary
The removal of Duke University cardiologist Robert Califf's name from consideration for FDA commissioner indicates that a record of government service and a strong public health background will trump all other qualifications for the post